is it safe to take cjc 1295 ipamorelin CJC-1295 + Tirzepatide, CJC‑1295/Ipamorelin | Metabolic Reset

tefan, Ljubljana, Jan

A., Ercal, N

human long-term safety data is limited, so caution and monitoring are advised

L.ReedB

10.1016/S0891-5849(96)00550-3

Children 6 months to age 17 years Primary doses: Two doses four to eight weeks apart Booster doses: Not recommended at this time Immunocompromised: Three primary doses (first two doses four weeks apart and the third at least four weeks after the second dose) People ages 18 and older Primary doses: Two doses four to eight weeks apart Booster doses: At least five months after the second dose Immunocompromised: Three primary doses (first two doses four weeks apart and the third at least four weeks after the second dose) One booster (at least three months after the third primary dose) People ages 50 and older should get a second mRNA booster at least four months after the first booster